| |
|
| |
| 上西 紀夫 |
公立昭和病院 院長 |
| 消化器外科学 |
| Shimizu N, Inada K, Nakanishi H, Tsukamoto T, Ikehara Y, Kaminishi M, Kuramoto S, Sugiyama, A, Katsuyama T, Tatematsu M. Helicobacter pylori infection enhances glandular stomach carcinogenesis in Mongolian gerbils treated with chemical carcinogens. Carcinogenesis 20: 669- 676, 1999 |
| Kaneda A, Kaminishi M, Sugimura T, Ushijima T. Lysyl oxidase is a tumor-suppressor gene inactivated by methylation and loss of heterozygosity in human gastric cancers. Cancer Res 64: 6410-6415, 2004 |
| The Diversity of Gastric Carcinoma, Kaminishi M, Takubo K, Mafune K eds, Springer-Verlag, Tokyo, 2005 |
|
| |
| 江口 研二 |
帝京大学医学部附属病院 教授 |
| がん化学療法・緩和医療 |
| T Morita, M Miyashita, A Yamagishi, M Akiyama, N Akizuki, K Hirai, C Imura, M Kato, Y Kizawa, Y Shirahige, T Yamaguchi, K Eguchi. Effects of a programme of interventions on regional comprehensive palliative care for patients with cacner: a mixed-methods study. Lancet Oncol 2013; May 9 638-646 |
| Saito H, Yoshizawa H, Yoshimori K, Katakami N, Katsumata N, Kawahara M, Eguchi K, Efficacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin: a multicentre, randomized, double-blind, placebo-controlled phase 3 trial. Ann Oncol 2012 October 31, doi:10.1093 |
Takiguchi Y. Seto T. Nogami N. Shinkai T. Okamoto H. Minato K. Seki N. Eguchi K. Nishikawa M. Watanabe K., Long-term administration of second-line chemotherapy with S-1 and gemcitabine for platinum-resistant non-small cell lung cancer: a phase II study.
J Thorac Oncol 2011; 6: 156-60 |
|
| |
| 小菅 智男 |
独立行政法人国立がん研究センター中央病院
副院長 |
| 外科学 |
| Improved surgical results for hilar cholangiocarcinoma with procedures including major hepatic resection. Kosuge T, Yamamoto J, Shimada K, Yamasaki S, Makuuchi M. Ann Surg.230(5):663-671,1999. |
| A multicenter randomized controlled trial to evaluate the effect of adjuvant cisplatin and 5-fluorouracil therapy after curative resection in cases of pancreatic cancer. Kosuge T, Kiuchi T, Mukai K, Kakizoe T. Jpn J Clin Oncol 36:159-165, 2006. |
| A randomized phase III study comparing gemcitabine monotherapy with observation in patients with resected pancreatic cancer. Kosuge T, Ueno H, Matsuyama Y, Yamamoto J, Nakao A, Egawa S, Doi R, Monden M, Hatori T, Tanaka M. ECCO14 (European Cancer Conference), 2007/9, Barcelona, Spain. |
|
| |
| 佐々木 康綱 |
昭和大学医学部内科学講座腫瘍内科学部門 教授 |
| 腫瘍内科学、腫瘍薬理学 |
| Wataru Ichikawa, Kazuhiro Araki, ,Ken-ichi Fujita, Wataru Yamamoto, Hisashi Endo, Fumio Nagashima, Ryuhei Tanaka, Toshimichi Miya, Keiji Kodama, Yu Sunakawa, Masaru Narabayashi, Yuichi Ando, Yuko Akiyama, Kaori Kawara, Yasutsuna Sasaki UGT1A1*28 Genotype and Irinotecan-Induced Neutropenia: Dose Matters. J. Natl. Cancer Inst. 100:224-225,2008 |
| Y. Akiyama, K. Fujita, F. Nagashima, W. Yamamoto, H. Endo, Y. Sunakawa, K. Yamashita, H. Ishida, K. Mizuno, K. Araki, W. Ichikawa, T. Miya, M. Narabayashi, K. Kawara, M. Sugiyama, T. Hirose, Y. Ando, and Y. Sasaki. Genetic testing for UGT1A1*28 and *6 in Japanese patients who receive irinotecan chemotherapy. Ann Oncol 2008 |
| Dana Rathkopf, Glenn Liu, Michael A. Carducci, Mario A. Eisenberger, Aseem Anand, Michael J. Morris, Susan F. Slovin, Yasutsuna Sasaki, Shunji Takahashi, Seiichiro Ozono, Nga Kit Eliza Fung, Shinta Cheng, Jinping Gan, Marco Gottardis, Mary T. Obermeier, Jyotsna Reddy, Steven Zhang, Blisse J. Vakkalagadda, Leila Alland, George Wilding, and Howard I. Scher Phase I Dose-Escalation Study of the Novel Antiandrogen BMS-641988 in Patients with Castration-Resistant Prostate Cancer Clin Cancer Res February 15, 2011 17:880-887; doi:10.1158/1078-0432.CCR-10-2955 |
|
| |
| 田村 和夫 |
福岡大学医学医学科 教授 |
| 臨床腫瘍学 |
Prognostic index for acute- and lymphoma-type adult T-cell leukemia/
lymphoma. Katsuya H, Yamanaka T, Ishitsuka K, Utsunomiya A, Sasaki H,
Hanada S, Eto T, Moriuchi Y, Saburi Y, Miyahara M, Sueoka E, Uike N,
Yoshida S, Yamashita K, Tsukasaki K, Suzushima H, Ohno Y, Matsuoka H,
Jo T, Suzumiya J, Tamura K: J Clin Oncol. 30(14): 1635-40, 2012 |
THP-COP regimen for the treatment of peripheral T-cell lymphoma and adult
T-cell leukemia/lymphoma: a multicenter phase II study. Takamatsu Y,
Suzumiya J, Utsunomiya A, Maeda K, Matsuoka H, Suzushima H, Tsukada J,
Shibata K, Tamura K; the Kyushu Hematology Organization for Treatment
Study Group (K-HOT). Eur J Haematol. 84(5): 391-7, 2010 |
| Pilot study of Irinotecan and S-1 for advanced and metastatic breast cancer. Tanaka M, Furusawa H, Kamada Y, Sagara Y, Anan K, MiyaraK, Kai Y, Wakamatsu S, Uga T, Tamura K, Mitsuyama S, Kyushu Breast Cancer Study Group. San Antonio Breast Cancer Symposium 2010 |
|
| ○ |
| 土屋 了介 |
公益財団法人がん研究会 理事 |
| 胸部外科学 |
| Asamura H, Goya T, Koshiishi Y, Sohara Y, Eguchi K, Mori M, Nakanishi Y, Tsuchiya R, Shimokata K, Inoue H, Nukiwa T, Miyaoka E; Japanese Joint Committee of Lung Cancer Registry.:A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers.: J Thorac Oncol. 2008 Jan;3(1):46-52 |
| Spaggiari L, Thomas P, Magdeleinat P, Kondo H, Rollet G, Regnard JF, Tsuchiya R, Pastorino U: Superior vena cava resection with prosthetic replacement for non-small cell lung cancer: long-term results of a multicentric study: Eur J Cardiothorac Surg. 2002 Jun; 21(6):1080-6. |
| Tsuchiya R, Suzuki K, Ichinose Y, Watanabe Y, Yasumitsu T, Ishizuka N, Kato H: Phase II trial of postoperative adjuvant cisplatin and etoposide in patients with completely resected stage I-IIIa small cell lung cancer: the Japan Clinical Oncology Lung Cancer Study Group Trial (JCOG9101). J Thorac Cardiovasc Surg. 2005 May; 129(5):977-83. |
|
| |
| 早川 和重 |
北里大学医学部放射線医学教室 教授 |
| 放射線腫瘍学 |
| Phase I results of vinorelbine with concurrent radiotherapy in elderly patients with unresectable, locally advanced non-small- cell lung cancer: West Japan Thoracic Oncology Group (WJTOG3005- DI). Harada H, Seto T, Igawa S, Tsuya A, Wada M, Kaira K, Naito T, Hayakawa K, Nishimura T, Masuda N, Yamamoto N. Int J Radiat Oncol Biol Phys. 2012 Apr;82(5):1777-82. |
| A phase II trial of neoadjuvant preoperative chemoradiotherapy with S-1 plus irinotecan and radiation in patients with locally advanced rectal cancer: clinical feasibility and response rate. Sato T, Ozawa H, Hatate K, Onosato W, Naito M, Nakamura T, Ihara A, Koizumi W, Hayakawa K, Okayasu I, Yamashita K, Watanabe M. Int J Radiat Oncol Biol Phys. 2011 Mar;79(3):677-83. |
| Phase I clinical study of NMK36: a new PET tracer with the synthetic amino acid analogue anti-[(18)F]FACBC. Asano Y, Inoue Y, Ikeda Y, Kikuchi K, Hara T, Taguchi C, Tokushige T, Maruo H, Takeda T, Nakamura T, Fujita T, Kumagai Y, Hayakawa K. Ann Nucl Med. 2011 Jul;25(6):414-8. |
|
